Effective treatment of acute graft-versus-host disease following liver transplantation using an integrated regimen centered on antithymocyte globulin: a single-center experience

Key Points

• ATG-based therapy improved outcomes in acute graft-versus-host disease after liver transplantation, indicating its potential effectiveness.
• Patients receiving antithymocyte globulin had better responses than those on conventional treatments, highlighting the need for further studies.
• Integrated diagnosis included examining clinical symptoms and chimerism detection to confirm acute graft-versus-host disease.
• Future research may focus on large-scale evaluations to validate the promising results observed in this series.